Is soy linked to breast cancer?

The objection

“Soy is full of plant oestrogens. For women, especially with breast cancer history, that has to raise the risk.”

The answer

It’s a reasonable fear and it deserves a straight answer. The evidence points the opposite way.

The worry rests on isoflavones, plant compounds that bind oestrogen receptors. But they bind weakly and preferentially to the beta receptor, which in breast tissue tends to oppose the proliferative signal that human oestrogen drives through the alpha receptor. The label “phytoestrogen” makes them sound like hormones in a syringe. They behave nothing like it.

What happens in real women eating real soy? Meta-analyses of epidemiological studies find higher soy intake is associated with the same or lower breast cancer risk, with the clearest protective signal in Asian populations and a dose-response pattern: more soy, lower risk. In Western cohorts the association is broadly neutral rather than harmful. Either way, the direction of the scare is not supported.

What surprises people most concerns survivors. Pooled cohort data link post-diagnosis soy intake to lower recurrence and lower mortality. On this basis the American Cancer Society states that women with breast cancer can eat soy safely.

A few caveats. Most of this is observational, so it shows association rather than proof of cause; the protection plateaus at ordinary food intakes, not megadosed isolated supplements; and “safe and probably protective” is not the same as “treats cancer.” But of all the things you could say about soy and breast tissue, “it causes breast cancer” is the one the evidence most clearly contradicts.